| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 DCHS2 SYT12 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 ADGRV1 RET PKD1L2 TENM2 FAT1 FAT2 NRXN1 PCDHGA12 ANKEF1 PCDHGA8 | 4.88e-05 | 749 | 180 | 19 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 TENM3 PTPRM PCDHGA12 PKD1 PCDHGA8 | 1.00e-10 | 187 | 180 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET TENM2 FAT1 FAT2 NRXN1 TENM3 PTPRM PCDHGA12 PKD1 PCDHGA8 | 2.36e-09 | 313 | 180 | 17 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 SETX MAP1A TRIO KALRN MYCBP2 TNC FAT3 TRIOBP CDH23 MPDZ ALS2 STMND1 ADGRV1 RET TECTA TENM2 BTBD3 NF1 NRXN1 TENM3 PTPRK PTPRM TRPV4 KDR MAP3K13 TNR MYO16 | 6.79e-06 | 1285 | 180 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | FAT3 TRIOBP CDH23 STOX1 TECTA FAT1 NF1 TENM3 PTPRM EPHA2 KDR LARGE1 | 5.05e-05 | 343 | 180 | 12 | GO:0090596 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 ADGRV1 RET TENM2 SLC6A4 FAT1 FAT2 NRXN1 TENM3 PTPRM PCDHGA12 PKD1 B4GALNT2 TRPV4 PLEKHA7 TNR PCDHGA8 | 6.67e-05 | 1077 | 180 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron development | HSPG2 SETX MAP1A TRIO KALRN MYCBP2 TNC FAT3 TRIOBP CDH23 MPDZ ALS2 STMND1 ADGRV1 RET TECTA TENM2 BTBD3 NF1 NRXN1 TENM3 PTPRK PTPRM TRPV4 KDR MAP3K13 TNR MYO16 | 7.02e-05 | 1463 | 180 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 PLOD3 SLC39A3 TNC FAT3 TRIOBP CDH23 STOX1 TECTA TULP3 STAT6 SLC6A4 ESRP2 FAT1 NF1 TENM3 PTPRM EPHA2 PKD1 HEY2 TRPV4 KDR CSMD1 JHY LARGE1 | 1.14e-04 | 1269 | 180 | 25 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 PLOD3 SLC39A3 MAP1A TRIO KALRN MYCBP2 FAT3 TRIOBP CDH23 ALS2 RET TECTA TENM2 BTBD3 FAT1 NRXN1 PTPRM EPHA2 CGN KDR MAP3K13 TNR MYO16 | 1.17e-04 | 1194 | 180 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.32e-04 | 171 | 180 | 8 | GO:0048593 | |
| GeneOntologyCellularComponent | cell-cell junction | AKAP6 MPP3 DCHS2 THEMIS COL17A1 OBSCN MPDZ TENM2 ABCB1 FAT1 FAT2 NRXN1 PTPRK PTPRM PCDHGA12 EPHA2 FHOD1 CGN NHS TRPV4 PLEKHA7 | 5.72e-08 | 591 | 183 | 21 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | AKAP6 MPP3 HSPG2 DCHS2 THEMIS COL17A1 TNC OBSCN TRIOBP MPDZ TENM2 ABCB1 SLC6A4 FAT1 FAT2 NRXN1 PTPRK PTPRM PCDHGA12 EPHA2 FHOD1 SYNE2 CGN NHS TRPV4 KDR PLEKHA7 | 1.15e-07 | 976 | 183 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | calcium channel complex | 4.34e-05 | 73 | 183 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | tenascin complex | 4.52e-04 | 4 | 183 | 2 | GO:0090733 | |
| MousePheno | abnormal synapse morphology | HSPG2 SETX KALRN MYCBP2 ALS2 NBEA RET SYNE2 NEMF TNR UTRN GPRASP2 | 3.44e-06 | 224 | 144 | 12 | MP:0009538 |
| MousePheno | abnormal neuromuscular synapse morphology | 5.96e-06 | 95 | 144 | 8 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 7.52e-06 | 98 | 144 | 8 | MP:0001051 | |
| MousePheno | abnormal startle reflex | UBL7 ABCA2 KALRN SGSH TMEM51 WDR81 TRIOBP CDH23 MPDZ ADGRV1 CMYA5 CHRNB3 SLC6A4 KCND3 B4GALNT2 NHS CSMD1 ENPEP SENP7 | 1.02e-05 | 591 | 144 | 19 | MP:0001486 |
| Domain | Cadherin | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.00e-09 | 113 | 181 | 12 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.11e-09 | 114 | 181 | 12 | PS50268 |
| Domain | - | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.11e-09 | 114 | 181 | 12 | 2.60.40.60 |
| Domain | CA | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.23e-09 | 115 | 181 | 12 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.36e-09 | 116 | 181 | 12 | IPR015919 |
| Domain | Cadherin | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 RET FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.66e-09 | 118 | 181 | 12 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 FAT1 FAT2 PCDHGA12 PCDHGA8 | 8.79e-09 | 109 | 181 | 11 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDHGA9 PCDHGA7 FAT3 PCDHAC1 PCDHA13 CDH23 FAT1 FAT2 PCDHGA12 PCDHGA8 | 1.29e-08 | 113 | 181 | 11 | PS00232 |
| Domain | SPEC | 5.60e-07 | 32 | 181 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.60e-07 | 32 | 181 | 6 | IPR018159 | |
| Domain | Cadherin_tail | 1.38e-06 | 37 | 181 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 1.38e-06 | 37 | 181 | 6 | IPR031904 | |
| Domain | ConA-like_dom | HSPG2 FAT3 NBEA ADGRV1 CMYA5 MEP1A FSD1L FAT1 FAT2 NRXN1 PTPRK PTPRM | 1.56e-06 | 219 | 181 | 12 | IPR013320 |
| Domain | FN3 | KALRN TNC OBSCN CMYA5 LEPR FSD1L PTPRK PTPRM EPHA2 HCFC2 TNR | 1.95e-06 | 185 | 181 | 11 | SM00060 |
| Domain | FN3 | KALRN TNC OBSCN CMYA5 LEPR FSD1L PTPRK PTPRM EPHA2 HCFC2 TNR | 3.96e-06 | 199 | 181 | 11 | PS50853 |
| Domain | fn3 | 4.13e-06 | 162 | 181 | 10 | PF00041 | |
| Domain | FN3_dom | KALRN TNC OBSCN CMYA5 LEPR FSD1L PTPRK PTPRM EPHA2 HCFC2 TNR | 6.33e-06 | 209 | 181 | 11 | IPR003961 |
| Domain | EGF | 1.91e-05 | 235 | 181 | 11 | SM00181 | |
| Domain | LAM_G_DOMAIN | 3.13e-05 | 38 | 181 | 5 | PS50025 | |
| Domain | EGF-like_dom | 3.25e-05 | 249 | 181 | 11 | IPR000742 | |
| Domain | - | 3.85e-05 | 95 | 181 | 7 | 2.60.120.200 | |
| Domain | Cadherin_2 | 3.92e-05 | 65 | 181 | 6 | PF08266 | |
| Domain | Cadherin_N | 3.92e-05 | 65 | 181 | 6 | IPR013164 | |
| Domain | Laminin_G_2 | 4.04e-05 | 40 | 181 | 5 | PF02210 | |
| Domain | ERAP1-like_C_dom | 4.84e-05 | 8 | 181 | 3 | IPR024571 | |
| Domain | ERAP1_C | 4.84e-05 | 8 | 181 | 3 | PF11838 | |
| Domain | EGF-like_CS | 4.98e-05 | 261 | 181 | 11 | IPR013032 | |
| Domain | Cadherin_C | 5.14e-05 | 42 | 181 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.14e-05 | 42 | 181 | 5 | PF16492 | |
| Domain | EGF_2 | 5.72e-05 | 265 | 181 | 11 | PS01186 | |
| Domain | LamG | 6.47e-05 | 44 | 181 | 5 | SM00282 | |
| Domain | Spectrin | 6.54e-05 | 23 | 181 | 4 | PF00435 | |
| Domain | TRPV5/TRPV6 | 9.34e-05 | 2 | 181 | 2 | IPR008344 | |
| Domain | Secretoglobin_1C1/2 | 9.34e-05 | 2 | 181 | 2 | IPR028659 | |
| Domain | EGF_3 | 1.02e-04 | 235 | 181 | 10 | PS50026 | |
| Domain | CRAL_TRIO | 1.26e-04 | 27 | 181 | 4 | PS50191 | |
| Domain | TRP_channel | 1.39e-04 | 11 | 181 | 3 | IPR004729 | |
| Domain | CRAL-TRIO_dom | 1.46e-04 | 28 | 181 | 4 | IPR001251 | |
| Domain | Spectrin_repeat | 1.68e-04 | 29 | 181 | 4 | IPR002017 | |
| Domain | Peptidase_M1 | 1.85e-04 | 12 | 181 | 3 | IPR001930 | |
| Domain | EGF_1 | 1.98e-04 | 255 | 181 | 10 | PS00022 | |
| Domain | EGF | 2.29e-04 | 126 | 181 | 7 | PF00008 | |
| Domain | HTH_Tnp_Tc5 | 2.38e-04 | 13 | 181 | 3 | PF03221 | |
| Domain | Peptidase_M1_N | 2.38e-04 | 13 | 181 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 2.38e-04 | 13 | 181 | 3 | PF01433 | |
| Domain | Laminin_G | 2.45e-04 | 58 | 181 | 5 | IPR001791 | |
| Domain | Rhs_assc_core | 2.78e-04 | 3 | 181 | 2 | IPR022385 | |
| Domain | ARM-like | 3.13e-04 | 270 | 181 | 10 | IPR011989 | |
| Domain | MAM_1 | 4.57e-04 | 16 | 181 | 3 | PS00740 | |
| Domain | MAM | 5.51e-04 | 17 | 181 | 3 | SM00137 | |
| Domain | Tox-GHH_dom | 5.53e-04 | 4 | 181 | 2 | IPR028916 | |
| Domain | Tox-GHH | 5.53e-04 | 4 | 181 | 2 | PF15636 | |
| Domain | Ten_N | 5.53e-04 | 4 | 181 | 2 | IPR009471 | |
| Domain | Ten_N | 5.53e-04 | 4 | 181 | 2 | PF06484 | |
| Domain | REJ | 5.53e-04 | 4 | 181 | 2 | PS51111 | |
| Domain | TENEURIN_N | 5.53e-04 | 4 | 181 | 2 | PS51361 | |
| Domain | REJ_dom | 5.53e-04 | 4 | 181 | 2 | IPR014010 | |
| Domain | MAM | 6.56e-04 | 18 | 181 | 3 | PF00629 | |
| Domain | MAM_dom | 6.56e-04 | 18 | 181 | 3 | IPR000998 | |
| Domain | MAM_2 | 6.56e-04 | 18 | 181 | 3 | PS50060 | |
| Domain | RCC1 | 9.04e-04 | 20 | 181 | 3 | PF00415 | |
| Domain | PHR | 9.16e-04 | 5 | 181 | 2 | IPR012983 | |
| Domain | YD | 9.16e-04 | 5 | 181 | 2 | IPR006530 | |
| Domain | PHR | 9.16e-04 | 5 | 181 | 2 | PF08005 | |
| Domain | RCC1_1 | 1.05e-03 | 21 | 181 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.05e-03 | 21 | 181 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.05e-03 | 21 | 181 | 3 | PS50012 | |
| Domain | - | 1.20e-03 | 22 | 181 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.20e-03 | 22 | 181 | 3 | IPR000408 | |
| Domain | PKD/REJ-like | 1.37e-03 | 6 | 181 | 2 | IPR002859 | |
| Domain | REJ | 1.37e-03 | 6 | 181 | 2 | PF02010 | |
| Domain | RCC1/BLIP-II | 1.37e-03 | 23 | 181 | 3 | IPR009091 | |
| Domain | SEC14 | 1.76e-03 | 25 | 181 | 3 | SM00516 | |
| Domain | STAT_TF_DNA-bd_sub | 1.90e-03 | 7 | 181 | 2 | IPR012345 | |
| Domain | STAT | 1.90e-03 | 7 | 181 | 2 | IPR001217 | |
| Domain | STAT_int | 1.90e-03 | 7 | 181 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.90e-03 | 7 | 181 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.90e-03 | 7 | 181 | 2 | PF02864 | |
| Domain | STAT_int | 1.90e-03 | 7 | 181 | 2 | PF02865 | |
| Domain | - | 1.90e-03 | 7 | 181 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.90e-03 | 7 | 181 | 2 | PF01017 | |
| Domain | Peptidase_C48_C | 1.90e-03 | 7 | 181 | 2 | IPR003653 | |
| Domain | - | 1.90e-03 | 7 | 181 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.90e-03 | 7 | 181 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.90e-03 | 7 | 181 | 2 | IPR015988 | |
| Domain | Peptidase_C48 | 1.90e-03 | 7 | 181 | 2 | PF02902 | |
| Domain | - | 1.90e-03 | 7 | 181 | 2 | 2.60.40.630 | |
| Domain | ULP_PROTEASE | 1.90e-03 | 7 | 181 | 2 | PS50600 | |
| Domain | - | HSPG2 TRIO KALRN MYCBP2 TNC OBSCN CMYA5 LEPR FSD1L PTPRK PTPRM EPHA2 KDR HCFC2 TNR | 2.06e-03 | 663 | 181 | 15 | 2.60.40.10 |
| Domain | STAT_TF_alpha | 2.52e-03 | 8 | 181 | 2 | IPR013800 | |
| Domain | ZINC_PROTEASE | 2.66e-03 | 98 | 181 | 5 | PS00142 | |
| Domain | BEACH | 3.22e-03 | 9 | 181 | 2 | PS50197 | |
| Domain | Beach | 3.22e-03 | 9 | 181 | 2 | PF02138 | |
| Domain | - | 3.22e-03 | 9 | 181 | 2 | 1.10.1540.10 | |
| Domain | Beach | 3.22e-03 | 9 | 181 | 2 | SM01026 | |
| Domain | BEACH_dom | 3.22e-03 | 9 | 181 | 2 | IPR000409 | |
| Domain | SCGB | 3.22e-03 | 9 | 181 | 2 | PS51311 | |
| Domain | DH_1 | 3.26e-03 | 63 | 181 | 4 | PS00741 | |
| Domain | ANK_REPEAT | 3.33e-03 | 253 | 181 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 3.41e-03 | 254 | 181 | 8 | PS50297 | |
| Pubmed | AKAP6 SRXN1 SESTD1 DCHS2 DMXL2 ABCA2 TRIO KALRN MYCBP2 NAP1L1 NAP1L2 TRIOBP TTC27 NBEA CMYA5 STAT6 WIZ PTPRK GRHPR GLS NEMF PKD1 RNF216 KDM4A ATIC UTRN GPRASP2 XRCC6 | 2.26e-10 | 1285 | 184 | 28 | 35914814 | |
| Pubmed | PLOD3 DDX31 TRIO CENPC MYCBP2 TMEM51 COPE TRIOBP TTC27 NBEA NCKAP5L TULP3 SHKBP1 RIF1 WIZ PTPRK PTPRM SYNE2 CGN MIOS NHS PLEKHA7 UTRN | 9.52e-09 | 1049 | 184 | 23 | 27880917 | |
| Pubmed | AKAP6 UBL7 SMG1 HSPG2 DMXL2 TRIO KALRN MYCBP2 OBSCN NAP1L1 CMYA5 TULP3 SYNE2 HEY2 UTRN XRCC6 | 1.11e-08 | 497 | 184 | 16 | 23414517 | |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 16059920 | ||
| Pubmed | SESTD1 DMXL2 TRIO KALRN MYCBP2 SENP3 WDR81 TRIOBP MPDZ NBEA GRM2 TENM2 NF1 MDN1 WIZ NRXN1 MAGED2 SYNE2 MIOS TNR XRCC6 | 4.82e-08 | 963 | 184 | 21 | 28671696 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | HSPG2 SESTD1 TNC BTBD18 WDR81 ALS2 LEPR MDN1 ASPM NHS UTRN SENP7 LARGE1 | 8.17e-08 | 363 | 184 | 13 | 14691545 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX OBSCN NBEA STOX1 CPT1B ESRP2 SLC6A6 MDN1 WIZ GTF3C1 GRHPR DENND4B PKD1 ATIC TNR UTRN XRCC6 PSMG4 | 8.66e-08 | 736 | 184 | 18 | 29676528 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.14e-07 | 72 | 184 | 7 | 10380929 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 29874579 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.46e-07 | 3 | 184 | 3 | 15744052 | |
| Pubmed | 1.82e-07 | 77 | 184 | 7 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.37e-07 | 80 | 184 | 7 | 10716726 | |
| Pubmed | SETX AHCTF1 SENP3 NOL6 NAP1L1 POLA2 INTS3 NCAPH TASOR2 IBTK GTF3C1 INTS2 RTL9 RAD21 | 2.38e-07 | 469 | 184 | 14 | 27634302 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | TRHDE SMG1 SETX TNC BTBD18 NOL6 MUC16 RET NF1 MAGED2 EPHA2 KDR PLEKHA7 | 4.32e-07 | 420 | 184 | 13 | 28065597 |
| Pubmed | DDX31 MYCBP2 AHCTF1 NOL6 NAP1L1 TASOR2 RIF1 NF1 MDN1 GTF3C1 SYNE2 CGN ATIC UTRN XRCC6 RAD21 | 4.56e-07 | 653 | 184 | 16 | 22586326 | |
| Pubmed | Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development. | 5.80e-07 | 4 | 184 | 3 | 9510027 | |
| Pubmed | 8.26e-07 | 33 | 184 | 5 | 19834762 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX CENPC MYCBP2 AHCTF1 SENP3 NOL6 NAP1L1 TTC27 NCAPH RIF1 NF1 MDN1 GTF3C1 MAGED2 GRHPR FHOD1 GLS ASPM MMS19 ATIC ALDH9A1 UTRN XRCC6 | 8.80e-07 | 1353 | 184 | 23 | 29467282 |
| Pubmed | AKAP6 SMG1 ABCA2 SETX MARCHF6 TRIOBP ADGRV1 NCAPH IBTK INTS2 HMGXB3 KDM4A PPIP5K2 RAD21 | 9.96e-07 | 529 | 184 | 14 | 14621295 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | COPE SENP3 NAP1L1 NCAPH RIF1 MDN1 WIZ GTF3C1 MAGED2 UTRN XRCC6 RAD21 | 1.44e-06 | 394 | 184 | 12 | 27248496 |
| Pubmed | Assembly of high order G alpha q-effector complexes with RGS proteins. | 1.45e-06 | 5 | 184 | 3 | 18936096 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.68e-06 | 68 | 184 | 6 | 11230163 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CCDC134 HSPG2 UXS1 ABCA2 PLOD3 MAN2B2 SYT12 MYCBP2 SGSH COPE MARCHF6 RTN3 PTDSS2 SLC6A6 FAT1 NF1 GTF3C1 TENM3 PTPRK EPHA2 FHOD1 | 1.76e-06 | 1201 | 184 | 21 | 35696571 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HSPG2 PLOD3 KALRN CETP AHCTF1 ADGRV1 TECTA ABCB1 FAT1 WIZ SLCO4C1 GRHPR PKD1 GNA11 ATIC ALDH9A1 PLEKHA7 UTRN ENPEP | 2.15e-06 | 1016 | 184 | 19 | 19056867 |
| Pubmed | SMG1 CENPC PCDHGA9 PCDHGA7 NOL6 STOX1 NCAPH CHRNB3 TASOR2 ABCB1 MDN1 GTF3C1 NRXN1 MAGED2 PCDHGA12 GLS SYNE2 ASPM KDR PPIP5K2 ATP12A PCDHGA8 XRCC6 | 2.57e-06 | 1442 | 184 | 23 | 35575683 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.78e-06 | 74 | 184 | 6 | 10817752 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.81e-06 | 281 | 184 | 10 | 28706196 | |
| Pubmed | 3.47e-06 | 225 | 184 | 9 | 12168954 | ||
| Pubmed | 3.61e-06 | 44 | 184 | 5 | 19322198 | ||
| Pubmed | SETX COPE SENP3 NOL6 MUC16 NBEA NCAPH BTBD3 TASOR2 RIF1 FAT1 WIZ TENM3 MAGED2 EPHA2 HCFC2 | 4.29e-06 | 777 | 184 | 16 | 35844135 | |
| Pubmed | UXS1 SETX PLOD3 DDX31 AHCTF1 SENP3 NOL6 NAP1L1 TRIOBP MPDZ SHKBP1 ATXN7L3 RIF1 MDN1 WIZ INTS2 KAT8 MIOS GNA11 HCFC2 PLEKHA7 UTRN RAD21 | 4.76e-06 | 1497 | 184 | 23 | 31527615 | |
| Pubmed | SMG1 DMXL2 SETX SENP3 NOL6 MPDZ INTS3 IBTK GTF3C1 WDCP NEMF RNF216 PPIP5K2 MOCOS | 1.06e-05 | 650 | 184 | 14 | 38777146 | |
| Pubmed | 1.20e-05 | 9 | 184 | 3 | 20182906 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.31e-05 | 57 | 184 | 5 | 32633719 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX31 MYCBP2 COPE SENP3 NOL6 IBTK RIF1 MDN1 GTF3C1 MAGED2 NEMF ASPM MIOS XRCC6 RAD21 | 1.40e-05 | 759 | 184 | 15 | 35915203 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.41e-05 | 28 | 184 | 4 | 15347688 | |
| Pubmed | 1.68e-05 | 151 | 184 | 7 | 17043677 | ||
| Pubmed | 1.68e-05 | 209 | 184 | 8 | 36779422 | ||
| Pubmed | The Nab2 and Stat6 genes share a common transcription termination region. | 1.70e-05 | 10 | 184 | 3 | 9126479 | |
| Pubmed | 1.74e-05 | 210 | 184 | 8 | 16565220 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.28e-05 | 218 | 184 | 8 | 33378226 | |
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 2.33e-05 | 11 | 184 | 3 | 16579977 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX DDX31 CENPC AHCTF1 POLA2 RIF1 WIZ GTF3C1 KAT8 KDM4A XRCC6 SENP7 RAD21 | 2.37e-05 | 608 | 184 | 13 | 36089195 |
| Pubmed | 2.50e-05 | 288 | 184 | 9 | 23383273 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 PLOD3 DDX31 MYCBP2 NOL6 NF1 GTF3C1 MAGED2 WDCP MIOS MMS19 | 2.51e-05 | 440 | 184 | 11 | 34244565 |
| Pubmed | Neuronal cell-surface protein neurexin 1 interaction with multi-PDZ domain protein MUPP1. | 2.78e-05 | 2 | 184 | 2 | 25036961 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15721841 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20178461 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22354706 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 2.78e-05 | 2 | 184 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 2.78e-05 | 2 | 184 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 2.78e-05 | 2 | 184 | 2 | 23968883 | |
| Pubmed | STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases. | 2.78e-05 | 2 | 184 | 2 | 39188021 | |
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 2.78e-05 | 2 | 184 | 2 | 30916584 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11488977 | ||
| Pubmed | Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. | 2.78e-05 | 2 | 184 | 2 | 15458778 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15491993 | ||
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 2.78e-05 | 2 | 184 | 2 | 11846401 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24761864 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12077127 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 35681468 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24592736 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 2.78e-05 | 2 | 184 | 2 | 26858404 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23820479 | ||
| Pubmed | Attenuated expression of tenascin-C in ovalbumin-challenged STAT4-/- mice. | 2.78e-05 | 2 | 184 | 2 | 21205293 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24361808 | ||
| Pubmed | Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. | 2.78e-05 | 2 | 184 | 2 | 15942051 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10903759 | ||
| Pubmed | Epigenetic regulation of the alternatively activated macrophage phenotype. | 2.78e-05 | 2 | 184 | 2 | 19567879 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12874250 | ||
| Pubmed | The STAT4 and STAT6 pathways in pancreatitis-associated lung injury. | 2.78e-05 | 2 | 184 | 2 | 17109890 | |
| Pubmed | Neonatal tolerance in the absence of Stat4- and Stat6- dependent Th cell differentiation. | 2.78e-05 | 2 | 184 | 2 | 12370340 | |
| Pubmed | Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. | 2.78e-05 | 2 | 184 | 2 | 11549322 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19140341 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10553062 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24958102 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 36436563 | ||
| Pubmed | STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. | 2.78e-05 | 2 | 184 | 2 | 16713741 | |
| Pubmed | Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. | 2.78e-05 | 2 | 184 | 2 | 11290331 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25164318 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20620946 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 7782276 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 9743537 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15820310 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28107529 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19459213 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10227985 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 38892470 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17548589 | ||
| Pubmed | Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. | 2.78e-05 | 2 | 184 | 2 | 15034039 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12390878 | ||
| Pubmed | IL-12, while beneficial, is not essential for the host response to VSV encephalitis. | 2.78e-05 | 2 | 184 | 2 | 12458040 | |
| Pubmed | Tenascins and inflammation in disorders of the nervous system. | 2.78e-05 | 2 | 184 | 2 | 23269478 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11086031 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16565876 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12965077 | ||
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 2.78e-05 | 2 | 184 | 2 | 16705151 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 14688314 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20405023 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22025716 | ||
| Cytoband | 5q31 | 7.48e-06 | 115 | 184 | 6 | 5q31 | |
| GeneFamily | Cadherin related | 1.18e-09 | 17 | 126 | 6 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 1.81e-06 | 160 | 126 | 9 | 555 | |
| GeneFamily | Clustered protocadherins | 5.47e-06 | 64 | 126 | 6 | 20 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.28e-04 | 161 | 126 | 6 | 593 | |
| GeneFamily | Transient receptor potential cation channels | 9.53e-04 | 28 | 126 | 3 | 249 | |
| GeneFamily | SUMO specific peptidases | 9.89e-04 | 7 | 126 | 2 | 984 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.06e-03 | 29 | 126 | 3 | 396 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.16e-03 | 66 | 126 | 4 | 722 | |
| GeneFamily | Ankyrin repeat domain containing | 1.55e-03 | 242 | 126 | 7 | 403 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.68e-03 | 9 | 126 | 2 | 1230 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 3.57e-03 | 13 | 126 | 2 | 533 | |
| GeneFamily | Secretoglobins | 4.15e-03 | 14 | 126 | 2 | 734 | |
| GeneFamily | Integrator complex | 4.77e-03 | 15 | 126 | 2 | 1366 | |
| GeneFamily | Aminopeptidases|CD molecules | 6.12e-03 | 17 | 126 | 2 | 104 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | ABCA2 ARPP21 SLC39A3 MAP1A FAT3 NBEA GCSH TENM2 NRXN1 PTPRK PKD1 GNAL CSMD1 MYO16 | 9.26e-06 | 488 | 183 | 14 | M39104 |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP | 1.17e-05 | 199 | 183 | 9 | M3915 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE DNAH10 KALRN FAT3 OBSCN ADGRV1 PKD1L2 FAT1 NRXN1 CSMD1 MYO16 | 3.06e-10 | 184 | 183 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE DNAH10 KALRN FAT3 OBSCN ADGRV1 PKD1L2 FAT1 NRXN1 CSMD1 MYO16 | 3.06e-10 | 184 | 183 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE DNAH10 KALRN FAT3 OBSCN ADGRV1 PKD1L2 FAT1 NRXN1 CSMD1 MYO16 | 3.06e-10 | 184 | 183 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | AKAP6 MPP3 OBSCN CMYA5 TENM2 KLHL31 PTPRM KCND3 PIP5K1B LARGE1 | 7.19e-09 | 191 | 183 | 10 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | AKAP6 MPP3 OBSCN CMYA5 TENM2 STAT4 KLHL31 KCND3 PIP5K1B LARGE1 | 8.34e-09 | 194 | 183 | 10 | c3535f7cc0076653c72db582047cff053c322397 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-08 | 179 | 183 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.91e-08 | 188 | 183 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.33e-08 | 189 | 183 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.76e-08 | 190 | 183 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 9.76e-08 | 190 | 183 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.07e-07 | 192 | 183 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-07 | 197 | 183 | 9 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-07 | 200 | 183 | 9 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-07 | 152 | 183 | 8 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-07 | 160 | 183 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-07 | 160 | 183 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.55e-07 | 161 | 183 | 8 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.61e-07 | 171 | 183 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-07 | 118 | 183 | 7 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-07 | 118 | 183 | 7 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.13e-07 | 173 | 183 | 8 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.40e-07 | 174 | 183 | 8 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.98e-07 | 176 | 183 | 8 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 178 | 183 | 8 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-07 | 178 | 183 | 8 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-07 | 125 | 183 | 7 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.99e-07 | 182 | 183 | 8 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.37e-07 | 183 | 183 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 186 | 183 | 8 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.10e-06 | 187 | 183 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.15e-06 | 188 | 183 | 8 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.19e-06 | 189 | 183 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 189 | 183 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-06 | 190 | 183 | 8 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.24e-06 | 190 | 183 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.29e-06 | 191 | 183 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.34e-06 | 192 | 183 | 8 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-06 | 193 | 183 | 8 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 195 | 183 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 196 | 183 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Cerebellum-Macroglia-CSF_related|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 137 | 183 | 7 | f004199b654143e9e766e5c5f56858089e98cf5f | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 137 | 183 | 7 | 6a5599af9d0ee1be6cac17af09aa4cd50774c683 | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 137 | 183 | 7 | 01cbc9082e10ef51a1763a8b2d708eea0434490f | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 137 | 183 | 7 | a22730b6f78b66bb3c46155af37c34e554672dee | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 137 | 183 | 7 | ce7c57dad201bd2164fc8b1172aca709f3f7def2 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-06 | 197 | 183 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-06 | 197 | 183 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-06 | 198 | 183 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 199 | 183 | 8 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-06 | 199 | 183 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.82e-06 | 200 | 183 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-06 | 200 | 183 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 3.37e-06 | 153 | 183 | 7 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.52e-06 | 154 | 183 | 7 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-06 | 154 | 183 | 7 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 155 | 183 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-06 | 155 | 183 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.53e-06 | 160 | 183 | 7 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.72e-06 | 161 | 183 | 7 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.55e-06 | 165 | 183 | 7 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 169 | 183 | 7 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 173 | 183 | 7 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 173 | 183 | 7 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-06 | 177 | 183 | 7 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-06 | 177 | 183 | 7 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.45e-06 | 179 | 183 | 7 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.45e-06 | 179 | 183 | 7 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 181 | 183 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 183 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.04e-05 | 120 | 183 | 6 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 183 | 183 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 183 | 183 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.09e-05 | 183 | 183 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 184 | 183 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 184 | 183 | 7 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.13e-05 | 184 | 183 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.14e-05 | 122 | 183 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 185 | 183 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 185 | 183 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.17e-05 | 185 | 183 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.21e-05 | 186 | 183 | 7 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 186 | 183 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.21e-05 | 186 | 183 | 7 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.21e-05 | 186 | 183 | 7 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 187 | 183 | 7 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 187 | 183 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 187 | 183 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 187 | 183 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 187 | 183 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 187 | 183 | 7 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.30e-05 | 188 | 183 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 188 | 183 | 7 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 188 | 183 | 7 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.30e-05 | 188 | 183 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 188 | 183 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 188 | 183 | 7 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| Disease | Malignant neoplasm of breast | AKAP6 KALRN EFCAB13 OBSCN TECTA LEPR STAT4 ABCB1 RIF1 NF1 MAGED2 WDCP ANKEF1 SYNE2 HEY2 NHS KDR MAP3K13 ENPEP | 3.64e-05 | 1074 | 181 | 19 | C0006142 |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 6.21e-05 | 13 | 181 | 3 | C1846647 | |
| Disease | rectum adenocarcinoma (is_implicated_in) | 1.12e-04 | 3 | 181 | 2 | DOID:1996 (is_implicated_in) | |
| Disease | Hydrocephalus | 1.12e-04 | 3 | 181 | 2 | cv:C0020255 | |
| Disease | Congenital hydrocephalus | 1.12e-04 | 3 | 181 | 2 | cv:C0020256 | |
| Disease | facioscapulohumeral muscular dystrophy (implicated_via_orthology) | 1.12e-04 | 3 | 181 | 2 | DOID:11727 (implicated_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-04 | 16 | 181 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-04 | 16 | 181 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-04 | 16 | 181 | 3 | C4551479 | |
| Disease | Rolandic epilepsy | 1.20e-04 | 16 | 181 | 3 | Orphanet_1945 | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-04 | 16 | 181 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-04 | 16 | 181 | 3 | C0025237 | |
| Disease | Van Buchem disease | 1.45e-04 | 17 | 181 | 3 | C0432272 | |
| Disease | mean platelet volume | MPP3 KALRN PCDHGA9 PCDHGA7 LEPR SHKBP1 SLC6A4 SLC6A6 SCGB1C2 PCDHGA12 GLS SYNE2 CATSPERB GNA11 PCDHGA8 PSMG4 SCGB1C1 | 1.93e-04 | 1020 | 181 | 17 | EFO_0004584 |
| Disease | visceral adipose tissue measurement, body mass index | 2.02e-04 | 87 | 181 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | Osteochondrodysplasias | 2.05e-04 | 19 | 181 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 2.05e-04 | 19 | 181 | 3 | C0013366 | |
| Disease | DNA methylation | DCHS2 TRIO STMND1 IBTK MDN1 NRXN1 TENM3 PTPRM KCND3 GNAL CSMD1 TNR JHY | 2.20e-04 | 656 | 181 | 13 | GO_0006306 |
| Disease | Multiple Epiphyseal Dysplasia | 2.40e-04 | 20 | 181 | 3 | C0026760 | |
| Disease | response to cisplatin, platinum measurement | 3.17e-04 | 53 | 181 | 4 | EFO_0010154, GO_0072718 | |
| Disease | Insulinogenic index measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0009961 | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 3.70e-04 | 5 | 181 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | mental development measurement | 4.73e-04 | 25 | 181 | 3 | EFO_0008230 | |
| Disease | cholesteryl ester transfer protein measurement | 5.52e-04 | 6 | 181 | 2 | EFO_0009133 | |
| Disease | hydrocephalus (is_implicated_in) | 5.52e-04 | 6 | 181 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | 1,5 anhydroglucitol measurement | 7.38e-04 | 29 | 181 | 3 | EFO_0008009 | |
| Disease | taurochenodeoxycholic acid 3-sulfate measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0800584 | |
| Disease | radiation-induced disorder | 7.77e-04 | 67 | 181 | 4 | EFO_0009565 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 9.66e-04 | 71 | 181 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | PR interval | AKAP6 HSPG2 KALRN MYCBP2 OBSCN SLC6A4 FAT1 KCND3 SYNE2 HCFC2 | 1.02e-03 | 495 | 181 | 10 | EFO_0004462 |
| Disease | temporal horn of lateral ventricle volume measurement | 1.02e-03 | 72 | 181 | 4 | EFO_0010333 | |
| Disease | Unipolar Depression | 1.14e-03 | 259 | 181 | 7 | C0041696 | |
| Disease | Amphetamine-Related Disorders | 1.19e-03 | 75 | 181 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 1.19e-03 | 75 | 181 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 1.19e-03 | 75 | 181 | 4 | C0236804 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.31e-03 | 9 | 181 | 2 | DOID:264 (is_marker_for) | |
| Disease | multiple sclerosis, chronic lymphocytic leukemia | 1.31e-03 | 9 | 181 | 2 | EFO_0000095, MONDO_0005301 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 1.37e-03 | 78 | 181 | 4 | EFO_0005325 | |
| Disease | Nonsyndromic Deafness | 1.58e-03 | 81 | 181 | 4 | C3711374 | |
| Disease | alcohol consumption measurement | AKAP6 MPP3 DDX31 COPE NBEA ADGRV1 TENM2 BTBD3 STAT6 SLC6A4 TRBV23-1 NF1 NRXN1 PTPRK TTLL6 CSMD1 SENP7 | 1.73e-03 | 1242 | 181 | 17 | EFO_0007878 |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0801871 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 1.98e-03 | 11 | 181 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | Cutaneous Melanoma | 2.04e-03 | 41 | 181 | 3 | C0151779 | |
| Disease | obesity (implicated_via_orthology) | 2.18e-03 | 215 | 181 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease | 2.37e-03 | 12 | 181 | 2 | C0007959 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.52e-03 | 152 | 181 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 2.71e-03 | 566 | 181 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | apolipoprotein B measurement | DCHS2 DNAH10 CETP EFCAB13 WDR81 ABCB1 SLC6A4 NF1 SYNE2 C6orf15 STKLD1 | 2.74e-03 | 663 | 181 | 11 | EFO_0004615 |
| Disease | Brugada Syndrome 1 | 2.79e-03 | 13 | 181 | 2 | C4551804 | |
| Disease | Paroxysmal atrial fibrillation | 2.81e-03 | 156 | 181 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 2.81e-03 | 156 | 181 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.81e-03 | 156 | 181 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 3.14e-03 | 160 | 181 | 5 | C0004238 | |
| Disease | hearing impairment | 3.16e-03 | 98 | 181 | 4 | C1384666 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 3.24e-03 | 14 | 181 | 2 | EFO_0004708 | |
| Disease | early cardiac repolarization measurement | 3.24e-03 | 14 | 181 | 2 | EFO_0004885 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 3.24e-03 | 14 | 181 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.81e-03 | 51 | 181 | 3 | cv:CN043650 | |
| Disease | complement factor H-related protein 3 measurement | 3.96e-03 | 169 | 181 | 5 | EFO_0600056 | |
| Disease | Major Depressive Disorder | 3.98e-03 | 243 | 181 | 6 | C1269683 | |
| Disease | generalised epilepsy | 4.02e-03 | 52 | 181 | 3 | EFO_0005917 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | AKAP6 TRHDE ARPP21 NOL6 CDH23 NBEA TENM2 CHRNB3 NRXN1 PTPRK ERAP2 UTRN | 4.06e-03 | 801 | 181 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Congenital total cataract | 4.24e-03 | 16 | 181 | 2 | C0266539 | |
| Disease | Intrahepatic cholestasis of pregnancy | 4.24e-03 | 16 | 181 | 2 | EFO_0009048 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 4.24e-03 | 16 | 181 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Pheochromocytoma, Extra-Adrenal | 4.24e-03 | 16 | 181 | 2 | C1257877 | |
| Disease | human papilloma virus infection, oropharynx cancer | 4.25e-03 | 53 | 181 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | serum gamma-glutamyl transferase measurement | ARPP21 MAP1A SYT12 KALRN FSIP1 TRIOBP TENM2 NF1 PTPRM EPHA2 PKD1 CSMD1 STKLD1 | 4.35e-03 | 914 | 181 | 13 | EFO_0004532 |
| Disease | melanoma | 4.40e-03 | 248 | 181 | 6 | C0025202 | |
| Disease | uric acid measurement | SESTD1 FSIP1 FAT3 EFCAB13 TTC27 ADGRV1 POLA2 TENM2 PLAAT2 PIP5K1B | 4.59e-03 | 610 | 181 | 10 | EFO_0004761 |
| Disease | triglycerides in medium VLDL measurement | 4.71e-03 | 55 | 181 | 3 | EFO_0022155 | |
| Disease | depressive disorder (is_implicated_in) | 4.79e-03 | 17 | 181 | 2 | DOID:1596 (is_implicated_in) | |
| Disease | Astrocytosis | 4.79e-03 | 17 | 181 | 2 | C3887640 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.79e-03 | 17 | 181 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | renal fibrosis (implicated_via_orthology) | 4.79e-03 | 17 | 181 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Amyotrophic lateral sclerosis | 4.79e-03 | 17 | 181 | 2 | cv:C0002736 | |
| Disease | Lipidemias | 4.79e-03 | 17 | 181 | 2 | C1706412 | |
| Disease | Graves disease, thyrotoxic periodic paralysis | 4.79e-03 | 17 | 181 | 2 | EFO_0004237, MONDO_0019201 | |
| Disease | Gliosis | 4.79e-03 | 17 | 181 | 2 | C0017639 | |
| Disease | Hyperlipidemia | 4.79e-03 | 17 | 181 | 2 | C0020473 | |
| Disease | Hypertrophic Cardiomyopathy | 5.21e-03 | 57 | 181 | 3 | C0007194 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.28e-03 | 181 | 181 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Nuclear non-senile cataract | 5.37e-03 | 18 | 181 | 2 | C1112705 | |
| Disease | Nuclear cataract | 5.37e-03 | 18 | 181 | 2 | C0392557 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.74e-03 | 59 | 181 | 3 | EFO_0009658, GO_0009410 | |
| Disease | neuroblastoma | 5.75e-03 | 116 | 181 | 4 | EFO_0000621 | |
| Disease | cerebral microbleeds | 5.97e-03 | 19 | 181 | 2 | EFO_0010059 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 5.97e-03 | 19 | 181 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | Pheochromocytoma | 5.97e-03 | 19 | 181 | 2 | C0031511 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEELVGQELPYSLTS | 96 | Q9NWW9 | |
| RLLLASTSEVYGDPE | 196 | Q8NBZ7 | |
| LDPSVSSISYLLDVT | 421 | Q9UKU6 | |
| PVTTITGETFDYSEL | 1046 | Q9UMD9 | |
| YLPSDEGEKLSLSTS | 256 | Q05901 | |
| PVSALLLAEIYSEAG | 186 | P49189 | |
| GISLPDDTLLTSLYN | 2826 | Q96N23 | |
| DISLTGDPVITASYL | 231 | P11597 | |
| DTDIEKTVVLPGYSS | 651 | Q9H7T0 | |
| LYVLTGSSVPDLIVS | 481 | Q96PZ7 | |
| DAPVYEVTLTASLGT | 221 | Q8NHY0 | |
| TVVLTPTYSGEADAL | 506 | Q96Q42 | |
| AEGAITIELASYPIS | 311 | Q14416 | |
| TLTVLASDDPYGIFI | 1966 | Q8WXG9 | |
| IEPDTFYTASVILDG | 461 | Q9Y2F9 | |
| KEEELLSSIYGVPTT | 676 | Q9NU02 | |
| DSGYPETLVNLIVLS | 246 | O14579 | |
| LPLSDSGVIYDSDES | 2466 | Q8TDJ6 | |
| IIARSESLGPISELY | 296 | Q5BKX8 | |
| ESLGPISELYSDELS | 301 | Q5BKX8 | |
| FDTYLLISEDTPVGS | 36 | Q9H251 | |
| SAYVTEGLESPTIEE | 671 | Q9Y222 | |
| IGLETTYGELISLED | 826 | Q8IZT6 | |
| STSYILLPLEAATGI | 461 | Q9UBL0 | |
| ISYETLGPEELRSLL | 191 | Q14CW9 | |
| PGSYSIEVLLVVDDS | 256 | Q8WXS8 | |
| QLPETLSSVAILTDY | 1346 | Q149M9 | |
| LIGYVLDTDFVESLP | 91 | Q9ULW6 | |
| SLTGEISTLEGLDYE | 296 | Q9Y5G6 | |
| LRAYDGLSLPEDIET | 26 | P98160 | |
| LSDYSDIVTTLDLAP | 341 | O60216 | |
| TEESLEESVGKPLYL | 641 | Q68E01 | |
| IYTEFPDETLRSGEL | 746 | Q68E01 | |
| LDGLVETPTGYIESL | 56 | P55209 | |
| VTEDTLQGAPLSSYI | 491 | Q9Y5G5 | |
| SVDPNDSSLTLYLVV | 681 | Q9Y5G5 | |
| PANSETSDLTLYLVV | 681 | O60330 | |
| LPSLEDLLFYTIAEG | 136 | O94925 | |
| IIEKTPLIDSYSTEG | 1011 | P08183 | |
| VDSYDVILAGSPTEL | 111 | O60568 | |
| LPLEIFITSSGEEYS | 3546 | Q14517 | |
| YLSSVEGLDSSDPLR | 136 | Q9UBP5 | |
| ETSLELILSTTGYPF | 251 | Q8WXI7 | |
| TTLERYPDTLLGSTE | 56 | Q9UK17 | |
| TTGLSYLVDDPLLSV | 486 | Q9UK17 | |
| ISSELTDASYGPNLL | 46 | Q9H511 | |
| EGPISLALYLSDAEA | 496 | O95461 | |
| GDKEPTIDETYILTS | 1046 | Q9NU22 | |
| STVEGYLLQLSTDLP | 381 | Q9Y5Z7 | |
| EAEISVPYLTSITAL | 236 | P78559 | |
| YILLSTLEPTDAGIL | 346 | Q9UNF1 | |
| TYAGKEESLPEISLL | 741 | Q6NUN7 | |
| GEETLNYPDTTIDLS | 771 | O60524 | |
| PGLETSESLSDSLYD | 1311 | Q9HCH0 | |
| IPLDYAVEGTESSSI | 161 | Q9Y6X6 | |
| SLIPGLTLYSQDELS | 381 | P60608 | |
| SLPELLTSDSEGSYA | 1021 | Q9P2D0 | |
| TLTVLGAQPDLLSYE | 466 | Q96T76 | |
| AGEYSDPVTLETKAL | 286 | Q9BXM9 | |
| SYELSKLESTVGSPE | 336 | Q9H7Z6 | |
| DLGTDIIPSIALAYE | 826 | P54707 | |
| YLSTPDRIDLAESLG | 166 | Q9HBU1 | |
| ELAPYATILASIVDS | 1196 | Q12766 | |
| ELETGLLTVAAPLDY | 766 | Q9NYQ8 | |
| LAEDTIQGSPLSTYV | 491 | Q9Y5G4 | |
| TLEEGTIYLTAEPNT | 511 | O14986 | |
| LSASELIPYAEVLTS | 781 | Q9H0H0 | |
| STLDTYLVIEDLSPG | 2621 | O60229 | |
| DYVSAALGPLTTLLE | 501 | Q9H6R4 | |
| NLSTPYLEEDGTSIL | 721 | O75164 | |
| LYSDAPVSELSLELL | 516 | O60337 | |
| TSLLVDSILPGSSYE | 291 | P48357 | |
| ELYSPLSGEVTEINE | 111 | P23434 | |
| LLDAASYVSTSPLDL | 236 | Q96EN8 | |
| STEPGYEVLTDSEII | 436 | Q9Y4A0 | |
| VKPLLEEDTYTGTVS | 106 | Q07075 | |
| TPYTAPGESEILDLD | 596 | Q9ULB1 | |
| GSSLLILAPSEAEYV | 626 | Q9H8H2 | |
| EEVLDYSPVLGSFLI | 2361 | Q7Z442 | |
| ESSGLLTTTCPLDYE | 1671 | Q6V1P9 | |
| PVGYSVLTLSATDLE | 2461 | Q6V1P9 | |
| LYTGEISTTRPLDEV | 626 | Q9Y5I0 | |
| SVSLVDYTPTDQDLL | 171 | P38405 | |
| DDESRAGTPSLVTYL | 4806 | Q5VST9 | |
| SYELLDVISEGPSAS | 481 | Q9H158 | |
| LLTGEIPYKDVDSSA | 346 | O43283 | |
| TGLEVSLTTDELLYP | 636 | B2RXH4 | |
| RLGEALPEELSYLSS | 126 | Q6UXA7 | |
| PYTLITTAVSADLGT | 436 | P57057 | |
| EFYLSVGSPSVLLDA | 151 | Q03188 | |
| SVTLDDLAPDTTYLV | 491 | P29317 | |
| QLESYLPGILEDISS | 1216 | A8TX70 | |
| ISDSGDRIALLSYSP | 2001 | A8TX70 | |
| LEPDSLLTAVSASGY | 1021 | Q8N3K9 | |
| LTDVDRIATLGYLPT | 161 | P29992 | |
| GYTPDVLTDTTAELA | 101 | Q9UBQ7 | |
| IDPSTGVLYTAERLD | 1511 | Q8TDW7 | |
| LVSDTSTELSYILPS | 1266 | Q9BZC7 | |
| YIAAEELQSILPSTG | 471 | Q8IY85 | |
| NSTETPSAYDLLILT | 516 | Q9Y2E5 | |
| YTGPEEEASLEFLLT | 536 | O75064 | |
| TSSPALLEGLSYLES | 691 | Q6P179 | |
| SFLDDPLYGISVSLS | 536 | Q8NA03 | |
| LDEGLTSVETYTPAI | 1431 | Q8WYP5 | |
| SPSGYYLDTELSLEE | 76 | Q9Y613 | |
| AVSVIELYGILDPTT | 2146 | Q8IVF4 | |
| YLGVSSPFLAEVLSE | 666 | Q92523 | |
| LLVVSYSDSLLDPAT | 211 | Q3KNS1 | |
| SATYNLTAEEPIVGL | 1876 | P98161 | |
| LPFLITIDGESSNYI | 1216 | Q15262 | |
| DTEYEISVLLTRPGE | 346 | P28827 | |
| SALEIGYTSVTVPLL | 66 | Q96KK4 | |
| SGAESPELLTYEEVA | 361 | Q13368 | |
| YSLSPSKVSGDDVIE | 226 | O95197 | |
| LDSGTLSPLLSTSEY | 121 | Q8NET4 | |
| ADAVGEILLSLSYLP | 281 | Q8IV01 | |
| SGIRSSLLPTDYLVE | 1861 | P46939 | |
| EISIISGELELSYPL | 641 | Q9BQF6 | |
| EVEGQITSLVDLYPS | 406 | P31641 | |
| YPTSLAIFSEELDGL | 246 | Q494U1 | |
| QSYLTLESGAVPLLE | 5231 | Q8WXH0 | |
| GITLLTLTEYDLRSP | 41 | Q96LT4 | |
| DLPYLEESTLTTAAL | 1161 | Q6T4R5 | |
| TGTYDSELLEQLSPL | 901 | Q5UIP0 | |
| DSGVVSLIETLLNYP | 636 | Q96D09 | |
| LTYEGSVNLDSITDP | 2521 | Q8NFP9 | |
| LGYVTLLEETPQDTA | 76 | Q9BVG9 | |
| ILYPAIVGTISLSSE | 1856 | Q96Q15 | |
| TGGIYLDDITLTETP | 416 | Q16819 | |
| TLLVGTPEELYEGTL | 36 | P0DMR2 | |
| LRSYVSEPELATLSG | 981 | Q6IQ23 | |
| DPAEDGVTALSVYLT | 371 | Q8TBC3 | |
| ELGLLESPDIYTSSV | 201 | Q7Z333 | |
| STDYPLAETILLLGF | 81 | Q9BRY0 | |
| LAVDPVSGSLYVSDT | 1291 | Q9NT68 | |
| LLSIRYGLTPDTLDE | 2676 | Q9NT68 | |
| LELVKGTYTTDDSPS | 1796 | O75592 | |
| EGSLLYTESDPLETQ | 126 | Q9NWF9 | |
| SESSGAPIDLLYELV | 901 | O95785 | |
| EIGYTALSETESPRL | 81 | Q06520 | |
| TSDSITYDPLLDLIA | 351 | Q14181 | |
| GLPYTATIEDILSFL | 481 | Q9H6T0 | |
| SRYDSIPVSTSLLGD | 56 | Q5JS54 | |
| GQVSEAYVSLLDLTP | 306 | P51688 | |
| SRELEAVPYLEGLTT | 106 | Q9H2D6 | |
| DELSVTLDYLLSIPS | 41 | Q86VW0 | |
| ELSDYSPSEDLLSGL | 226 | Q13023 | |
| TGTLRTSLDPSLEIY | 21 | Q9H6E4 | |
| DSVYDPSSIASLLTE | 1181 | Q9P2M7 | |
| LDITTYGESNLVAEP | 611 | Q15003 | |
| IYSSEGFLVIDTSPD | 1581 | O75443 | |
| LDEFLQTYGSLIPLS | 321 | Q9H4L4 | |
| TPGLQLEEDITDSYL | 476 | Q8N1K5 | |
| LFVYPEESLVIGSST | 366 | P12956 | |
| LDIFSSYTGRDIPEL | 1111 | O75970 | |
| GETETTLLVTKPLYE | 166 | Q9NXC5 | |
| LIPTLIDDYEGFKTS | 406 | Q96MW7 | |
| LASYEEILPELVSSS | 621 | Q8NE28 | |
| LYTLGTAFLDDSVPT | 246 | Q6ZQN7 | |
| IAIPSEDILYTTLGT | 156 | Q6ZVD7 | |
| CLYGLTIDLETSSLP | 436 | Q14765 | |
| YVTSLLLNEPDGTFL | 546 | P42226 | |
| TLSDLRVYLGASTPD | 121 | Q9BYN0 | |
| VIVGPDTTSYSLADL | 1931 | P24821 | |
| LTDLEPGAEYIISVT | 741 | Q92752 | |
| ISLPSYESLTGLDET | 156 | Q9NW97 | |
| SILRLPETELGEYSL | 21 | Q96S82 | |
| GPLTSTLYDLTEIDS | 311 | Q9H1D0 | |
| TYLPGIDEETSEESL | 2741 | P21359 | |
| TLLPSGAEVLSYSEA | 56 | Q687X5 | |
| SLAASPDGTLYIADL | 1476 | Q9P273 | |
| TLLVGTPEELYEGTL | 36 | Q8TD33 | |
| IIAPGYEEEALTILS | 341 | P31939 | |
| LVSYTPDLLLSVRGE | 546 | Q8N841 | |
| LAILSSEPGDTALYL | 96 | A0A0A0MS06 | |
| SLIYDDGLSEEETPL | 1026 | P07949 | |
| GESYDVTLTTTEKPL | 131 | H3BQB6 | |
| DPSAYILEVSTALDL | 266 | Q5VWN6 | |
| DGKDYIVLPISETLS | 1171 | P35968 | |
| EDYEKLTPSGSISLI | 636 | O43314 | |
| SEVSVSSSYLEPLDL | 271 | Q9H6R7 | |
| VLQLELSGYSPEDLT | 1726 | Q12789 | |
| LSGYSPEDLTAALEI | 1731 | Q12789 | |
| SPYSIVELLESDNIS | 266 | Q96HH4 | |
| LSLLTLDGESIYSLT | 141 | Q6P3X3 | |
| LLEEYATGPAVLTVA | 491 | P31645 | |
| EIYDTIFAGLDLPST | 256 | P01266 | |
| NPIDLLESTLYESSV | 81 | Q9HBA0 | |
| ISIDPVDLSREGESY | 251 | O75386 | |
| GELAALYLESISPSS | 1511 | Q562E7 | |
| LLVGLLDTFETPTSY | 2851 | O75962 | |
| LTYVLLSGVSPFLDD | 2981 | O75962 | |
| GPLTSILYDLTEIDS | 271 | Q9NQA5 |